AAAAAA

   
Results: 1-7 |
Results: 7
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS
Authors: Bijker, N Rutgers, EJT Peterse, JL Fentiman, IS Julien, JP Duchateau, L van Dongen, JA
Citation: N. Bijker et al., Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS, EUR J SUR O, 27(2), 2001, pp. 135-140
Risk factors for recurrence and metastasis after breast-conserving therapyfor ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853
Authors: Bijker, N Peterse, JL Duchateau, L Julien, JP Fentiman, IS Duval, C Di Palma, S Simony-Lafontaine, J de Mascarel, I van de Vijver, MJ
Citation: N. Bijker et al., Risk factors for recurrence and metastasis after breast-conserving therapyfor ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853, J CL ONCOL, 19(8), 2001, pp. 2263-2271
Breast-conserving therapy for Paget disease of the nipple - A prospective European Organization for Research and Treatment of Cancer Study of 61 patients
Authors: Bijker, N Rutgers, EJT Duchateau, L Peterse, JL Julien, JP Cataliotti, L
Citation: N. Bijker et al., Breast-conserving therapy for Paget disease of the nipple - A prospective European Organization for Research and Treatment of Cancer Study of 61 patients, CANCER, 91(3), 2001, pp. 472-477
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinomain situ
Authors: Bijker, N Peterse, JL Duchateau, L Robanus-Maandag, EC Bosch, CAJ Duval, C Pilotti, S van de Vijver, MJ
Citation: N. Bijker et al., Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinomain situ, BR J CANC, 84(4), 2001, pp. 539-544
Adjuvant radiotherapy for DCIS - Authors' reply
Authors: Julien, JP Bijker, N Fentiman, IS Peterse, JL
Citation: Jp. Julien et al., Adjuvant radiotherapy for DCIS - Authors' reply, LANCET, 355(9220), 2000, pp. 2072-2073
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853
Authors: Julien, JP Bijker, N Fentiman, IS Peterse, JL Delledonne, V Rouanet, P Avril, A Sylvester, R Mignolet, F Bartelink, H Van Dongen, JA
Citation: Jp. Julien et al., Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853, LANCET, 355(9203), 2000, pp. 528-533
Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy
Authors: Bijker, N Rutgers, EJT Peterse, JL van Dongen, JA Hart, AAM Borger, JH Kroon, BBR
Citation: N. Bijker et al., Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy, CANCER, 85(8), 1999, pp. 1773-1781
Risultati: 1-7 |